C/O Sutro Biopharma, Inc., 111 Oyster Point Boulevard, South San Francisco, CA
Summary
The estimated net worth of Barbara Leyman is at least $127K dollars as of August 26, 2025. Barbara Leyman is the Chief Business Officer of SUTRO BIOPHARMA, INC. and owns shares of SUTRO BIOPHARMA, INC. (STRO) stock worth about $127K.
Signature
/s/ David Pauling as attorney-in-fact for Barbara Leyman
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.